Experience of Indinavir/Ritonavir 400/100 mg Twice-Daily Highly Active Antiretroviral Therapy-Containing Regimen in HIV-1-Infected Patients in Bamako, Mali-Reference-Cited by-同舟云学术

Experience of Indinavir/Ritonavir 400/100 mg Twice-Daily Highly Active Antiretroviral Therapy-Containing Regimen in HIV-1-Infected Patients in Bamako, Mali

Published:2007-08-01 Issue:4 Volume:45 Page:477-479
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Canestri Ana,Cisse Mamadou,Marcelin Anne-Geneviève,Peytavin Gilles,Traore Emmanuel,Assoumou Lambert,Traore Ousmane,Koita Victoria,Diallo Fodie,Sangare Awa Thiero,Sidibé Mayrama Koita,Calvez Vincent,Sylla Aliou,Katlama Christine,Tubiana Roland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference15 articles.

1. WHO launches guidelines to speed up delivery of antiretroviral drugs to HIV/AIDS patients.;Bull World Health Organ,2003

2. Antiretroviral drug resistance in non-subtype B HIV-1, HIV-2 and SIV.;Parkin;Antivir Ther,2004

3. Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.;Wester;J Acquir Immune Defic Syndr,2005

4. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.;Coetzee;AIDS,2004

5. High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote dIvoire.;Adje;J Acquir Immune Defic Syndr,2001

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Parameters of HIV‐1 Protease Inhibitors;ChemMedChem;2020-05-26

2. Indinavir;Meyler's Side Effects of Drugs;2016

3. Antiviral drugs;Side Effects of Drugs Annual;2010

4. Protease inhibitor therapy in resource-limited settings;Current Opinion in HIV and AIDS;2008-11